Startuphealth-2019年Q1医疗健康初创企业洞察-2019.4-20页_4mb

2019 Q1 StartUp Health Insights Summary

Core Content

The 2019 Q1 StartUp Health Insights report provides an in-depth analysis of the global health innovation market, highlighting key trends, investment patterns, and the progress being made toward achieving major health goals known as "Health Moonshots." The report emphasizes the shift from traditional "digital health" to a broader concept of "health innovation," which includes not only technology but also new business models and design thinking.

Main Points and Key Insights

Market Trends

• Total Funding: $2.8 billion in Q1 2019, a 3.7% dip from the previous year, but 37% fewer deals.
• Deal Size: The median deal size increased by 79%, indicating a more mature market with a focus on quality over quantity.
• Insurance Focus: Insurance emerged as the most funded function, driven largely by Clover Health's $500M raise.
• Global Spread: 36% of all funding occurred outside the U.S., with Paris, France leading non-U.S. metro areas with $276M in funding.

Health Moonshots

• Top Funded Moonshots:
  • Cost to Zero: $1.1 billion in funding, with a 40% increase in deals above $10M.
  • Access to Care: Second most funded, with 74% of funding coming from web and mobile apps.
  • Women's Health: Showed a significant increase from $7.8M to $91.6M, with a 89% rise in average deal size.
  • Cure Disease: Saw a major dip in funding compared to Q1 2018, but still had notable deals like Beam Therapeutics.
  • Nutrition & Fitness: Global and mobile-focused, with 8 deals from different countries.
  • Children's Health: Remains underfunded, with only $8.8M in median deal size.

Investment Spectrum

• Top Functions by Funding:
  • Insurance: $656.5M
  • Patient Empowerment: $405.2M
  • Wellness: $420.6M
  • Research: $326.5M
  • Clinical Workflow: $314.1M
  • Biometric Data Acquisition: $242.1M
• Top Deals in Q1 2019:
  • Clover Health ($500M)
  • Doctolib ($170M)
  • Taimei Medical Technology ($80M)
  • Shuidichou ($74M)
  • Miaoshou Doctor ($73M)
  • Dental Monitoring ($51M)

Investors

• Top Active Investors:
  • GV (4 deals)
  • F-Prime Capital Partners (4 deals)
  • Balderton Capital (3 deals)
  • Sands Capital Ventures (3 deals)
  • Wells Fargo Strategic Capital (3 deals)
• Investor Growth: 11% of investors have backed two or more companies, showing increased engagement and cross-pollination of expertise.

Hubs of Innovation

• Top U.S. Metro Areas:
  • San Francisco: $991.8M
  • New York City: $186.5M
  • Boston: $278.5M
• Top Non-U.S. Metro Areas:
  • Paris, France: $276M
  • Beijing, China: $147M
  • Tel Aviv, Israel: $126M

Key Takeaways

• The market is maturing, with larger, more impactful deals.
• Insurance and Patient Empowerment are the most funded functions.
• Global innovation is growing, with new hubs like Lausanne, Switzerland and Athens, Greece emerging.
• Women's Health and Cost to Zero are seeing increased investment and positive trends.
• Children's Health and Brain Health remain underfunded, presenting opportunities for new entrepreneurs and investors.
• Clover Health is a standout with its massive raise, signaling strong interest in InsureTech and Medicare Advantage.

Summary of Key Data

• Total Funding: $2.8 billion
• Total Deals: 48
• Median Deal Size: $10M
• Unique Investors: 115
• Countries Tracked: 83
• Cities Tracked: 511

Call to Action

StartUp Health encourages entrepreneurs and investors to identify areas where innovation is still needed, such as Children's Health and Brain Health, and to collaborate to achieve the Health Moonshots. The report underscores the importance of radical collaboration and audacious goals in driving meaningful change in the global health landscape.